1.SCI's major business is including below three (3) items:
(1)APIs, API intermediates, special and Custom Synthesis (Development , manufacturing)(2)Supporting for bidding and distribution of products from domestic and overseas manufacturers as a local partner.
(3)Represent for Development of products in item 2.
2. Sales
Unit:NTD in thousandProduct | Y2022 | Ratio |
API | 450,223 | 50.04% |
Intermediate | 433,362 | 48.16% |
Others | 16,153 | 1.80% |
Total | 899,738 | 100.00% |
3.Product list and Services:
Category | Product list |
API
| VA Probucol Divalproate Sodium Propafenone Hydrochloride Duloxetine Hydrochloride Allopurinol Clindamycin palmitate HCl Articaine Hydrochloride HOCLQ-Sulfate Brinzolamide Sodium Valproate Pentobarbital Sodium Methylphenidate HCl Biso-FA必 Thiopental acid Loxoprofen Sodium Hydrate Atomoxetine HCl Cannabidiol Adenine Buprenorphine |
Intermediates | DEDPM |
Specialty Chemical | DEK... etc. total in 7 items |
4. Sales volume/value in the most recent 2 years:
Unit: Ton / Unit: thousand NT$
Year | 2021 | 2022 | ||||||
---|---|---|---|---|---|---|---|---|
Sales Volume/Value | Domestic Sales | Export | Domestic Sales | Export | ||||
Primary Product | Volume | Value | Volume | Value | Volume | Value | Volume | Value |
APIs | 18.80 | 43,717 | 62.95 | 352,885 | 50.16 | 101,413 | 133.90 | 348,810 |
API intermediates | 17.48 | 4,447 | 161.73 | 447,468 | 0.40 | 1,166 | 123.81 | 432,196 |
Others | 42.6 | 10,415 | 19.09 | 5,285 | 181.66 | 6,740 | (18.98) | 9,413 |
Total | 78.88 | 58,579 | 243.77 | 805,638 | 232.22 | 109,319 | 238.73 | 790,419 |